Binding sites for peptide-histidine-isoleucine (PHI) on rat insulinoma-derived RINm5F cellsGÖKE, R; CONLON, J. M.Molecular and cellular endocrinology. 1988, Vol 60, Num 2-3, pp 211-215, issn 0303-7207, 5 p.Article

Analysis of low molecular mass GTP-binding proteins in insulinoma-derived RINm5F cells by two-dimensional gel electrophoresisGOKE, R; GOKE, B.Hormone and metabolic research. 1991, Vol 23, Num 6, pp 304-305, issn 0018-5043Article

Receptors for glucagon-like peptide-1(7-36) amide on rat insulinoma-derived cellsGÖKE, R; CONLON, J. M.Journal of endocrinology. 1988, Vol 116, Num 3, pp 357-362, issn 0022-0795Article

Effects of islet-activating protein on insulin- and isoprenaline-stimulated glucose transport in isolated rat adipocytesJOOST, H. G; GÖKE, R.FEBS letters. 1984, Vol 167, Num 1, pp 5-9, issn 0014-5793Article

At the cutting edge glucagon-like peptide-1(7-37)/(7-36)amide is a new incretinFEHMAN, H.-C; GÖKE, R; GÖKE, B et al.Molecular and cellular endocrinology. 1992, Vol 85, Num 1-2, pp C39-C44, issn 0303-7207Article

Influence of a low molecular weight serine proteinase inhibitor (camostate) on lipolysis of isolated adipocytesGÖKE, B; GÖKE, R; LANKISCH, P. F et al.Research in experimental medicine. 1985, Vol 185, Num 6, pp 503-507, issn 0300-9130Article

Amylin alters the biological action of the incretin hormone GLP-1(7-36)amideGÖKE, R; MCGREGOR, G. P; GÖKE, B et al.Life sciences (1973). 1993, Vol 53, Num 17, pp 1367-1372, issn 0024-3205Article

Dexamethasone pretreatment of rat insulinoma cells decreases binding of glucagon-like peptide-1(7-36)amideRICHTER, G; GÖKE, R; GÖKE, B et al.Journal of endocrinology. 1990, Vol 126, Num 3, pp 445-450, issn 0022-0795, 6 p.Article

Entero-insuläre Achse: Der heue inkretin-kandidat glucagon-like peptide-1(7-36) amid(GLP-1(7-36) amid) = L'axe entéroinsulaire: un nouveau peptide glucagon-like 1(7-36) amide GLP-1(7-36 amide) = The enteroinsular axis: glucagon-like peptide-1(7-36) amide (GLP-1(7-36) amide) ― a new incretin candidateGÖKE, R; GÖKE, B; RICHTER, G et al.Zeitschrift für Gastroenterologie. 1988, Vol 26, Num 11, pp 715-719, issn 0044-2771Article

Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in GermanyGÖKE, R; GRUENBERGER, J. B; BADER, G et al.Current medical research and opinion. 2014, Vol 30, Num 5, pp 785-789, issn 0300-7995, 5 p.Article

Biological actions of glucagon-like peptide(GLP)-2 revealed : how pluripotential is the glucagon gene ?MCGREGOR, G. P; GÖKE, R; GÖKE, B et al.Experimental and clinical endocrinology & diabetes. 1998, Vol 106, Num 1, pp 25-28, issn 0947-7349Conference Paper

Das Darmhormon Glucagon-like peptide-1 (GLP-1) : aus dem Experiment in die Klinik = Glucagon-like peptide-1 (GLP-1) : A gut hormone on its way from bench to besideGÖKE, B; FEHMANN, H.-C; SCHIRRA, J et al.Zeitschrift für Gastroenterologie. 1997, Vol 35, Num 4, pp 285-294, issn 0044-2771Article

Physiology and pathophysiology of GLP-1GÖKE, B; GÖKE, R; FEHMANN, H.-C et al.Handbook of experimental pharmacology. 1996, Vol 123, pp 275-309, issn 0171-2004Article

Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and manEISSELE, R; GÖKE, R; WILLEMER, S et al.European journal of clinical investigation. 1992, Vol 22, Num 4, pp 283-291, issn 0014-2972Article

Expression of the ras-related rab3a gene in insulinoma-derived cell linesLANKAT-BUTTGEREIT, B; GÖKE, R; FEHMANN, H.-C et al.FEBS letters. 1992, Vol 312, Num 2-3, pp 183-186, issn 0014-5793Article

Internalization of glucagon-like peptide-1(7-36)amide in rat insulinoma cellsGÖKE, R; RICHTER, G; GÖKE, B et al.Research in experimental medicine. 1989, Vol 189, Num 4, pp 257-264, issn 0300-9130, 8 p.Article

Neuropeptide Y2 receptors on nerve endings from the rat neurohypophysis regulate vasopressin and oxytocin releaseSHEIKH, S. P; FELDTHUS, N; ORKILD, H et al.Neuroscience. 1998, Vol 82, Num 1, pp 107-115, issn 0306-4522Article

Characterization of insulin-like growth factor II receptors in human small cell lung cancer cell linesSCHARDT, C; ROTSCH, M; ERBIL, C et al.Experimental cell research. 1993, Vol 204, Num 1, pp 22-29, issn 0014-4827Article

Solubilization of active receptors for glucagon-like peptide-1(7-36)amide from rat lung membranesGÖKE, R; KOLLIGS, F; RICHTER, G et al.American journal of physiology. Lung cellular and molecular physiology. 1993, Vol 8, Num 2, pp L146-L152, issn 1040-0605Article

Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting β-cellsGÖKE, R; FEHMANN, H.-C; LINN, T et al.The Journal of biological chemistry (Print). 1993, Vol 268, Num 26, pp 19650-19655, issn 0021-9258Article

Glucagon-like peptide 1(7-36)amide receptors in the lungRICHTER, G; FEDDERSEN, O; WAGNER, U et al.Digestion. 1993, Vol 54, Num 6, issn 0012-2823, p. 344Conference Paper

How do individual meal constituents influence the release of GLP-1 in humans ?GÖKE, R; RICHTER, G; KOLLIGS, F et al.Digestion. 1993, Vol 54, Num 6, issn 0012-2823, p. 380Conference Paper

Characterisation of the expression and post-translational processing of the preprotachykinin-I gene and the regulated release of tachykinins by the RINm5F cell-lineMCGREGOR, G. P; HARTEL, R; FEHMANN, H.-C et al.FEBS letters. 1992, Vol 312, Num 2-3, pp 187-191, issn 0014-5793Article

Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21^Waf1/Cip1GÖKE, R; BARTH, P; SCHMIDT, A et al.American journal of physiology. Cell physiology. 2004, Vol 56, Num 6, pp C1541-C1546, issn 0363-6143Article

Investigation of the processing of GLP-1(7-36)amide by membrane peptidasesMCGREGOR, G. P; HUPE-SODMANN, K; BRIDENBAUGH, R et al.Digestion. 1993, Vol 54, Num 6, issn 0012-2823, p. 373Conference Paper